I've had HepC for about 30 years. Last year, I did the Sovaldi/Ribavirin therapy. 12 weeks into treatment, I was virus-free, continued that way through the 24-wk. treatment, but had relapsed by my 3-month, post-treatment labs in December. A liver biopsy in March told me I have cirrhosis-not critical stage, but still....I'm wondering if any new drug therapies have been recently FDA-approved that target Genotype 3?